Promising Phase 3 Results for Epcoritamab Combined with R-CHOP in DLBCL Treatment #USA #Epcoritamab #AbbVie #North_Chicago #DLBCL
@newsen.bsky.social
@newsen.bsky.socialPromising Phase 3 Results for Epcoritamab Combined with R-CHOP in DLBCL Treatment #USA #Epcoritamab #AbbVie #North_Chicago #DLBCL
@hemehub.bsky.social🩸The HemeHub Hematology Summit is just 2 days away!
Here’s a preview of the schedule, bringing together expert insights and panel discussions for a full day of learning!
Full program and event details: hemehub.org/events/hemeh...
#HemeHub #HemeOnc #Myelofibrosis #MultipleMyeloma #CLL #PNH #DLBCL
@oncologynurseadv.bsky.socialIt's #WorldLymphomaAwarenessDay! 💚
Metformin maintenance was associated with improved treatment response and survival among patients with diffuse large B-cell #Lymphoma (#DLBCL) and #HGBL!
Read about the research here: https://bit.ly/4Ab8I3K
@ihi-synthia.bsky.social🩸 This #BloodCancerAwarenessMonth, discover how SYNTHIA is exploring #SyntheticData to advance research in #DLBCL & #MultipleMyeloma — from clinical trials to treatment outcome prediction.
🔗 www.ihi-synthia.eu/use-cases
#BloodCancer #SYNTHIA #EUResearch #IHITransformingHealth #HorizonEU
@hemehub.bsky.social🌟 Our DLBCL case discussion with Sairah Ahmed, MD, and Elif Yilmaz, MD is now available to watch on YouTube!
⮕ Watch the full session: youtu.be/EMPaDlO5lto
@cancers-mdpi.bsky.social🏅Editor's Choice #Review
#Lipid Metabolism Reprogramming in Diffuse Large B-Cell Lymphoma (#DLBCL): Mechanisms and Treatment Strategies
🧑🔬Yue-E Ding, Yi-Ran Zhong et al.
Unlock🔓 www.mdpi.com/2072-6694/18...
#lymphoma #metabolism #ImmuneMicroenvironment #ferroptosis
@hemehub.bsky.social🩸📢 The links for the HemeHub Hematology Summit have been updated!
Registration: hemehub.org/events/hemeh...
Full program and event details:
hemehub.org/events/hemeh...
🗓️ October 3, 2026
📍 Gaylord Texan Resort & Convention Center
#HemeHub #HemeOnc #Myelofibrosis #MultipleMyeloma #CLL #PNH #DLBCL